Ignite Creation Date:
2024-05-06 @ 6:09 PM
Last Modification Date:
2024-10-26 @ 2:42 PM
Study NCT ID:
NCT05565105
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-05
First Post:
2022-09-28
Brief Title:
CD34 Transplants for Leukemia and Lymphoma
Sponsor:
Guenther Koehne
Organization:
Baptist Health South Florida
Study Overview
Official Title:
A Phase II Trial of CD34 Enriched Transplants From HLA-Compatible Related or Unrelated Donors for Treatment of Patients With Leukemia or Lymphoma
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will evaluate whether processing blood stem cell transplants using an investigational device the CliniMACS system results in less complications for patients undergoing transplant for treatment of a blood malignancy cancer or blood disorder
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None